TY - CHAP
T1 - Regulation of indoleamine 2,3-dioxygenase, the first enzyme in UV filter biosynthesis in the human lens
T2 - Ninth Meeting of the "International Study Group for Tryptophan Research" (lSTRY)
AU - Takikawa, Osamu
AU - Littlejohn, Tamantha
AU - Jamie, Joanne F.
AU - Walker, Mark J.
AU - Truscott, Roger J. W.
PY - 1999
Y1 - 1999
N2 - 3-Hydroxykynurenine (3OHKyn), the precursor of UV filters in human lens, is highly autooxidizable, generates H2O2, and binds to lens proteins, yielding a tanned/yellow product resembling senile nuclear cataractous materials. Thus, if 3OHkyn can be shown to be the causative agent in cataract, it may be possible to prevent the disease by lowering the level of 3OHKyn. To this end, indoleamine 2,3-dioxygenase, the first enzyme in UV filter synthesis, was studied using lens epithelial cell lines. The results indicated that the IDO expression is mediated by IFN-γ. Immuno-suppressants which inhibit production of IFN-γ may act as anti-cataract agents. Another way to lower the level of 3OHKyn is to use specific inhibitors for IDO. A recombinant human IDO was expressed to develop the inhibitors.
AB - 3-Hydroxykynurenine (3OHKyn), the precursor of UV filters in human lens, is highly autooxidizable, generates H2O2, and binds to lens proteins, yielding a tanned/yellow product resembling senile nuclear cataractous materials. Thus, if 3OHkyn can be shown to be the causative agent in cataract, it may be possible to prevent the disease by lowering the level of 3OHKyn. To this end, indoleamine 2,3-dioxygenase, the first enzyme in UV filter synthesis, was studied using lens epithelial cell lines. The results indicated that the IDO expression is mediated by IFN-γ. Immuno-suppressants which inhibit production of IFN-γ may act as anti-cataract agents. Another way to lower the level of 3OHKyn is to use specific inhibitors for IDO. A recombinant human IDO was expressed to develop the inhibitors.
UR - http://www.scopus.com/inward/record.url?scp=0034466508&partnerID=8YFLogxK
U2 - 10.1007/978-1-4615-4709-9_31
DO - 10.1007/978-1-4615-4709-9_31
M3 - Chapter
C2 - 10721062
AN - SCOPUS:0034466508
SN - 9781461371335
T3 - Advances in experimental medicine and biology
SP - 241
EP - 245
BT - Tryptophan, serotonin, and melatonin
PB - Springer, Springer Nature
CY - New York
Y2 - 10 October 1998 through 14 October 1998
ER -